Hot Features
Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Ultragenyx Pharmaceutical Inc is a US-based biopharmaceutical company. It identifies, acquires, develops, and commercialize novel products for the treatment of serious rare and ultra-rare diseases, with the focus on serious, debilitating genetic diseases. The company's medicine portfolio includes Cr... Ultragenyx Pharmaceutical Inc is a US-based biopharmaceutical company. It identifies, acquires, develops, and commercialize novel products for the treatment of serious rare and ultra-rare diseases, with the focus on serious, debilitating genetic diseases. The company's medicine portfolio includes Crysvita and Mepsevii. Crysvita is indicated for the treatment of X-linked hypophosphatemia (XLH) in adult and pediatric patients 1 year of age and older. Mehr anzeigen
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -2.25 | -5.70486815416 | 39.44 | 39.87 | 36.2 | 694694 | 38.54676092 | CS |
| 4 | -5.56 | -13.0058479532 | 42.75 | 43.22 | 36.2 | 730376 | 39.36845679 | CS |
| 12 | -4.32 | -10.4071308119 | 41.51 | 46.5 | 36.2 | 778930 | 41.67711923 | CS |
| 26 | -17.03 | -31.4090741424 | 54.22 | 57.995 | 36.2 | 776546 | 45.58257021 | CS |
| 52 | -9.55 | -20.432178006 | 46.74 | 60.37 | 36.2 | 783274 | 45.76587782 | CS |
| 156 | -34.25 | -47.9423292273 | 71.44 | 85.53 | 31.52 | 733581 | 45.16876185 | CS |
| 260 | -6.89 | -15.6306715064 | 44.08 | 179.647 | 31.52 | 624483 | 59.92403301 | CS |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
